Edwards Lifesciences
EW
$70.37
Share price
1.31%
Change (1 day)
-15.82%
Change (1 year)
Categories
P/S ratio for Edwards Lifesciences (EW)
P/S ratio as of September 2023 (TTM): 7.56
According to Edwards Lifesciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.56201. At the end of 2023 the company had a P/S ratio of 10.1.
P/S ratio history for Edwards Lifesciences from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.1 | 17.95% |
| 2022 | 8.57 | -44.56% |
| 2021 | 15.5 | 19.25% |
| 2020 | 13.0 | 15.54% |
| 2019 | 11.2 | 31.29% |
| 2018 | 8.55 | 23.08% |
| 2017 | 6.94 | 2.71% |
| 2016 | 6.76 | -0.91% |
| 2015 | 6.82 | 15.41% |
| 2014 | 5.91 | 68.23% |
| 2013 | 3.51 | -35.24% |
| 2012 | 5.43 | 12.92% |
| 2011 | 4.80 | -25.22% |
| 2010 | 6.42 | 72.1% |
| 2009 | 3.73 | 51.07% |
| 2008 | 2.47 | 3.59% |
| 2007 | 2.39 | -8.82% |
| 2006 | 2.62 | 5.42% |
| 2005 | 2.48 | -5.72% |
| 2004 | 2.63 | 26.62% |
| 2003 | 2.08 | -4.5% |
| 2002 | 2.18 | -8.09% |
| 2001 | 2.37 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 3.33 | -55.98% | 🇮🇪 Ireland |
 Boston Scientific BSX | 5.77 | -23.66% | 🇺🇸 USA |
 Merit Medical MMSI | 3.24 | -57.17% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | 6.72 | -11.18% | 🇺🇸 USA |
 ICU Medical
ICUI | 1.21 | -83.96% | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |